Dr. Mostaghel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-288-1000Fax+1 206-288-1025
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2003 - 2006
University of California (San Francisco)Residency, Internal Medicine, 2000 - 2003
Duke University School of MedicineClass of 2000
Certifications & Licensure
CA State Medical License 2002 - Present
WA State Medical License 2003 - 2025
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers Start of enrollment: 2021 Aug 31
Roles: Contact
Publications & Presentations
PubMed
- Reproducible preclinical models of androgen receptor driven human prostate cancer bone metastasis.JuanJuan Yin, Asha Daryanani, Fan Lu, Anson T Ku, John R Bright
The Prostate. 2024-08-01 - 1 citationsSigma1 Regulates Lipid Droplet-mediated Redox Homeostasis Required for Prostate Cancer Proliferation.Halley M Oyer, Alexandra R Steck, Charles G Longen, Sanjana Venkat, Konuralp Bayrak
Cancer Research Communications. 2023-10-30 - 2 citationsONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate Cancer.Chen Qian, Qian Yang, Mirja Rotinen, Rongrong Huang, Hyoyoung Kim
Biorxiv. 2023-10-12
Journal Articles
- Neoadjuvant-Intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci with Diverse Subclonal Oncogenic AlterationsElahe Mostaghel, MD, Clinical Cancer Research
- Contribution of Adrenal Glands to Intra-Tumor Androgens and Growth of Castration Resistant Prostate CancerAlvin M Matsumoto, Maria S Tretiakova, Lawrence True, Elahe A Mostaghel, Clinical Cancer Research
- Downregulation of Dipeptidyl Peptidase 4 Accelerates Progression to Castration-Resistant Prostate CancerElahe Mostaghel, MD, Clinical Cancer Research
Press Mentions
Oral Relugolix Works to a T Against Advanced Prostate CancerMay 30th, 2020
Context Partners with Research Institutions to Study Sigma1 Protein in Treatment of Fibrosis, CancerAugust 21st, 2017
Grant Support
- In Vivo Efficacy Of Multi-Targeted Androgen Inhibition As Prostate Cancer TherapyNational Cancer Institute2006–2010
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
